Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Niraparib

Niraparib

Inquiry
  Post Date: Apr 19,2024
  Expiry Date: Oct 16,2024
  Detailed Description: Cas No. :1038915-60-4 Niraparib (trade name Zejula) is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer. Niraparib was granted fast track designation by the US Food and Drug Administration (FDA), and Tesaro submitted a new drug application in 2016.

  CAS Registry Number:

1038915-60-4
  Synonyms: ;(S)-2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide;

  Company: Changzhou Pharmaceutical Factory     [ China ]          
  Contact: Manager Shen;Joyce Zhang;Morena Xu
  Tel: +86-519-88821493;68010600
  Fax: +86-519-88828412;88256855
  Email: zhangyajuan@czpharma.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.